These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 14763510)
1. In vitro expansion of human hepatocytes is restricted by telomere-dependent replicative aging. Wege H; Chui MS; Le HT; Strom SC; Zern MA Cell Transplant; 2003; 12(8):897-906. PubMed ID: 14763510 [TBL] [Abstract][Full Text] [Related]
2. Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. Wege H; Le HT; Chui MS; Liu L; Wu J; Giri R; Malhi H; Sappal BS; Kumaran V; Gupta S; Zern MA Gastroenterology; 2003 Feb; 124(2):432-44. PubMed ID: 12557149 [TBL] [Abstract][Full Text] [Related]
3. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Vaziri H; Benchimol S Curr Biol; 1998 Feb; 8(5):279-82. PubMed ID: 9501072 [TBL] [Abstract][Full Text] [Related]
4. The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review). Engelhardt M; Martens UM Oncol Rep; 1998; 5(5):1043-52. PubMed ID: 9683806 [TBL] [Abstract][Full Text] [Related]
5. Stabilization of telomere length and karyotypic stability are directly correlated with the level of hTERT gene expression in primary fibroblasts. Cui W; Aslam S; Fletcher J; Wylie D; Clinton M; Clark AJ J Biol Chem; 2002 Oct; 277(41):38531-9. PubMed ID: 12122013 [TBL] [Abstract][Full Text] [Related]
6. Telomere length maintenance in aging and carcinogenesis. Aragona M; Maisano R; Panetta S; Giudice A; Morelli M; La Torre I; La Torre F Int J Oncol; 2000 Nov; 17(5):981-9. PubMed ID: 11029502 [TBL] [Abstract][Full Text] [Related]
7. Telomeres and telomerase: implications for cancer and aging. Shay JW; Wright WE Radiat Res; 2001 Jan; 155(1 Pt 2):188-193. PubMed ID: 11121233 [TBL] [Abstract][Full Text] [Related]
8. Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential. Rufer N; Migliaccio M; Antonchuk J; Humphries RK; Roosnek E; Lansdorp PM Blood; 2001 Aug; 98(3):597-603. PubMed ID: 11468156 [TBL] [Abstract][Full Text] [Related]
10. Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation. MacKenzie KL; Franco S; May C; Sadelain M; Moore MA Exp Cell Res; 2000 Sep; 259(2):336-50. PubMed ID: 10964501 [TBL] [Abstract][Full Text] [Related]
11. Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres. Goodwin EC; DiMaio D Cell Growth Differ; 2001 Nov; 12(11):525-34. PubMed ID: 11714633 [TBL] [Abstract][Full Text] [Related]
12. Telomeres, telomerase, and myc. An update. Cerni C Mutat Res; 2000 Jan; 462(1):31-47. PubMed ID: 10648922 [TBL] [Abstract][Full Text] [Related]
13. Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms. Davis T; Singhrao SK; Wyllie FS; Haughton MF; Smith PJ; Wiltshire M; Wynford-Thomas D; Jones CJ; Faragher RG; Kipling D J Cell Sci; 2003 Apr; 116(Pt 7):1349-57. PubMed ID: 12615976 [TBL] [Abstract][Full Text] [Related]
14. Extension of cell life span using exogenous telomerase. Kang MK; Park NH Methods Mol Biol; 2007; 371():151-65. PubMed ID: 17634580 [TBL] [Abstract][Full Text] [Related]
15. Genetic manipulation of telomerase in HIV-specific CD8+ T cells: enhanced antiviral functions accompany the increased proliferative potential and telomere length stabilization. Dagarag M; Evazyan T; Rao N; Effros RB J Immunol; 2004 Nov; 173(10):6303-11. PubMed ID: 15528369 [TBL] [Abstract][Full Text] [Related]
16. Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT. Röth A; Baerlocher GM; Schertzer M; Chavez E; Dührsen U; Lansdorp PM Blood; 2005 Jul; 106(1):43-50. PubMed ID: 15741219 [TBL] [Abstract][Full Text] [Related]
17. Reconstituting telomerase activity using the telomerase catalytic subunit prevents the telomere shorting and replicative senescence in human osteoblasts. Yudoh K; Matsuno H; Nakazawa F; Katayama R; Kimura T J Bone Miner Res; 2001 Aug; 16(8):1453-64. PubMed ID: 11499868 [TBL] [Abstract][Full Text] [Related]
18. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies. Babizhayev MA; Yegorov YE J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007 [TBL] [Abstract][Full Text] [Related]
19. Effects of telomerase modulation in human hematopoietic progenitor cells. Zimmermann S; Glaser S; Ketteler R; Waller CF; Klingmüller U; Martens UM Stem Cells; 2004; 22(5):741-9. PubMed ID: 15342938 [TBL] [Abstract][Full Text] [Related]
20. Extension of life-span by introduction of telomerase into normal human cells. Bodnar AG; Ouellette M; Frolkis M; Holt SE; Chiu CP; Morin GB; Harley CB; Shay JW; Lichtsteiner S; Wright WE Science; 1998 Jan; 279(5349):349-52. PubMed ID: 9454332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]